Dr. Daniel Landau
Claim this profileOrlando Health Cancer Institute
Area of expertise
Prostate Cancer
Daniel Landau has run 3 trials for Prostate Cancer. Some of their research focus areas include:
Kidney Cancer
Daniel Landau has run 3 trials for Kidney Cancer. Some of their research focus areas include:
Affiliated Hospitals
Orlando Health Cancer Institute
Orlando Health Inc., UF Health Cancer Center
Clinical Trials Daniel Landau is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
More about Daniel Landau
Clinical Trial Related
7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Daniel Landau has experience with
- Nivolumab
- Ipilimumab
- Docetaxel
- Daratumumab/rHuPH20
- Lenalidomide
- Abiraterone
Breakdown of trials Daniel Landau has run
Prostate Cancer
Kidney Cancer
Renal Cell Carcinoma
Cancer
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Landau specialize in?
Daniel Landau focuses on Prostate Cancer and Kidney Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Daniel Landau currently recruiting for clinical trials?
Yes, Daniel Landau is currently recruiting for 3 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Daniel Landau has studied deeply?
Yes, Daniel Landau has studied treatments such as Nivolumab, Ipilimumab, Docetaxel.
What is the best way to schedule an appointment with Daniel Landau?
Apply for one of the trials that Daniel Landau is conducting.
What is the office address of Daniel Landau?
The office of Daniel Landau is located at: Orlando Health Cancer Institute, Orlando, Florida 32806 United States. This is the address for their practice at the Orlando Health Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.